Mohammad Ahangari
Research Subjects
Mohammad Ahangari has a total of 293 co-authors. Here are the top co-authors by number of shared publications:
- Aligholi Niaei
Department of Physics, Faculty of Science, University of Sakarya, Sakarya, Turkey
6 shared publications Jafar Mostafaei
4 shared publicationsDavid Stern
Herasight Research, USA
3 shared publications- Elnaz Asghari
Electrochemistry Research Laboratory, Department of Physical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran
3 shared publications - Jeremiah H. Li
OpenAI
3 shared publications Michael Christensen
Herasight Research, USA
3 shared publications
Latest Publications
- Open Access
Prioritizing embryos with lower homozygosity is expected to reduce disease risk in children of related individuals undergoing preimplantation genetic testing
Consanguinity is a reproductive union between individuals who share a recent common ancestor. These unions are common in many regions of the world and increase the burden of rare recessive disorders by elevating autozygosity in offspring. Current reproductive genetic screening focuses on a limited set of known pathogenic variants, leaving most recessive risk unaddressed. Here we argue that embryo-level autozygosity, quantified as the fraction of the genome in long runs of homozygosity ( F ROH ), is a potentially actionable genomic biomarker that can be integrated into routine preimplantation genetic testing as a homozygosity-informed embryo-prioritization framework (PGT-H) that can be layered onto existing embryo biopsy workflows when couples are already undergoing IVF with PGT-A or PGT-M. Using forward simulations of first-cousin and double-first-cousin couples, we show that siblings conceived by the same couple span a wide range of F ROH ; selecting the lowest- F ROH candidate from a cohort of five embryos reduces F ROH by approximately 40% on average. Combining these reductions with empirical effect-size estimates, we estimate that for first-cousin couples this strategy could reduce risk of intellectual disability by roughly 35 – 45% (corresponding to an absolute risk reduction of about 1.8 – 2.2%) and potentially reduce excess recessive disease burden, while also modestly reducing risk of common diseases such as type 2 diabetes. We outline how existing PGT-A and PGT-M workflows could potentially be extended to report embryo-level F ROH and discuss ethical and counseling considerations. Autozygosity-based embryo prioritization offers a principled way to address a component of recessive risk that current variant-centric approaches miss.
Open AccessPrioritizing embryos with lower homozygosity is expected to reduce disease risk in children of related individuals undergoing preimplantation genetic testing
Consanguinity is a reproductive union between individuals who share a recent common ancestor. These unions are common in many regions of the world and increase the burden of rare recessive disorders by elevating autozygosity in offspring. Current reproductive genetic screening focuses on a limited set of known pathogenic variants, leaving most recessive risk unaddressed. Here we argue that embryo-level autozygosity, quantified as the fraction of the genome in long runs of homozygosity ( F ROH ), is a potentially actionable genomic biomarker that can be integrated into routine preimplantation genetic testing as a homozygosity-informed embryo-prioritization framework (PGT-H) that can be layered onto existing embryo biopsy workflows when couples are already undergoing IVF with PGT-A or PGT-M. Using forward simulations of first-cousin and double-first-cousin couples, we show that siblings conceived by the same couple span a wide range of F ROH ; selecting the lowest- F ROH candidate from a cohort of five embryos reduces F ROH by approximately 40% on average. Combining these reductions with empirical effect-size estimates, we estimate that for first-cousin couples this strategy could reduce risk of intellectual disability by roughly 35 – 45% (corresponding to an absolute risk reduction of about 1.8 – 2.2%) and potentially reduce excess recessive disease burden, while also modestly reducing risk of common diseases such as type 2 diabetes. We outline how existing PGT-A and PGT-M workflows could potentially be extended to report embryo-level F ROH and discuss ethical and counseling considerations. Autozygosity-based embryo prioritization offers a principled way to address a component of recessive risk that current variant-centric approaches miss.
- Open Access
Comparative Evaluation of Cross-Ancestry Polygenic Risk Scoring of Type 1 Diabetes in the All of Us Cohort
Type 1 diabetes is a highly heritable autoimmune condition characterized by the destruction of pancreatic beta cells, resulting in insulin deficiency. Here, we developed a novel polygenic score we call the HLA-Augmented SBayesRC Framework (HLA-ARC). HLA-ARC integrates direct modeling of HLA haplotypes, with a Bayesian regression approach for the non-HLA component. SBayesRC leverages extensive functional genomic annotations and linkage disequilibrium patterns across approximately 7.4 million variants, substantially enhancing predictive accuracy. We systematically compared HLA-ARC to three existing T1D polygenic scores (Polygenic Risk Score extension for Diabetes Mellitus [PRSedm], Trans-Ancestry Polygenic Score for Diabetes [TA-PS], and Type 1 Diabetes Multi-Ancestry Polygenic Score [T1D-MAPS]) using data from the ancestrally-diverse All of Us cohort. Among the three existing methods, T1D-MAPS showed superior performance in all ancestry groups. However, HLA-ARC consistently outperformed the existing methods, achieving AUROC values exceeding 0.91 in European individuals and 0.89 in non-European groups. Our results demonstrate that integrating HLA haplotype modeling with genomic annotation and ancestry-informed linkage disequilibrium methods significantly improves polygenic risk prediction for autoimmune diseases characterized by major genetic risk loci.
Open AccessComparative Evaluation of Cross-Ancestry Polygenic Risk Scoring of Type 1 Diabetes in the All of Us Cohort
Type 1 diabetes is a highly heritable autoimmune condition characterized by the destruction of pancreatic beta cells, resulting in insulin deficiency. Here, we developed a novel polygenic score we call the HLA-Augmented SBayesRC Framework (HLA-ARC). HLA-ARC integrates direct modeling of HLA haplotypes, with a Bayesian regression approach for the non-HLA component. SBayesRC leverages extensive functional genomic annotations and linkage disequilibrium patterns across approximately 7.4 million variants, substantially enhancing predictive accuracy. We systematically compared HLA-ARC to three existing T1D polygenic scores (Polygenic Risk Score extension for Diabetes Mellitus [PRSedm], Trans-Ancestry Polygenic Score for Diabetes [TA-PS], and Type 1 Diabetes Multi-Ancestry Polygenic Score [T1D-MAPS]) using data from the ancestrally-diverse All of Us cohort. Among the three existing methods, T1D-MAPS showed superior performance in all ancestry groups. However, HLA-ARC consistently outperformed the existing methods, achieving AUROC values exceeding 0.91 in European individuals and 0.89 in non-European groups. Our results demonstrate that integrating HLA haplotype modeling with genomic annotation and ancestry-informed linkage disequilibrium methods significantly improves polygenic risk prediction for autoimmune diseases characterized by major genetic risk loci.
- Open Access
Development and validation of polygenic scores for within-family prediction of disease risks
The clinical implementation of polygenic scores (PGSs) for disease risk prediction, particularly in reproductive health applications, requires rigorous validation. Here, we develop seventeen disease PGSs by conducting large-scale GWAS meta-analyses, and we validate our scores in out-of-sample prediction analyses. We achieve state-of-the-art predictive performance, consistently matching or outperforming academic and commercial benchmarks, with liability R 2 reaching up to 0.21 (type 2 diabetes). The performance of a PGS for embryo screening depends on its predictive ability within-family, which can be lower than its prediction ability among unrelated individuals. However, very few disease PGSs have been tested within-family. We perform systematic within-family validation of our disease PGSs, finding no decrease in predictive performance within-family for 16 of 17 scores. PGS performance typically declines with genetic distance from training data, an effect that needs to be accounted for to give properly calibrated predictions across ancestries. We perform extensive calibration of our scores’ performance across different ancestries, finding improved cross-ancestry performance compared to previous approaches, especially in African and East Asian populations. This is likely due to the fact our scores are constructed using a method that incorporates functional genomic annotations on more than 7 million variants, enabling a degree of fine-mapping of causal variants shared across ancestries. We illustrate clinical utility through examining the risk reduction that could be achieved through embryo screening for type 2 diabetes: selecting among 10 embryos is expected to reduce absolute disease risk by 12-20% in families where both parents are affected, with similar relative risk reductions across ancestries. These findings establish a framework for implementing PGS in reproductive medicine while demonstrating both the technology’s potential for disease prevention and the methodological standards required for responsible clinical translation.
Open AccessDevelopment and validation of polygenic scores for within-family prediction of disease risks
The clinical implementation of polygenic scores (PGSs) for disease risk prediction, particularly in reproductive health applications, requires rigorous validation. Here, we develop seventeen disease PGSs by conducting large-scale GWAS meta-analyses, and we validate our scores in out-of-sample prediction analyses. We achieve state-of-the-art predictive performance, consistently matching or outperforming academic and commercial benchmarks, with liability R 2 reaching up to 0.21 (type 2 diabetes). The performance of a PGS for embryo screening depends on its predictive ability within-family, which can be lower than its prediction ability among unrelated individuals. However, very few disease PGSs have been tested within-family. We perform systematic within-family validation of our disease PGSs, finding no decrease in predictive performance within-family for 16 of 17 scores. PGS performance typically declines with genetic distance from training data, an effect that needs to be accounted for to give properly calibrated predictions across ancestries. We perform extensive calibration of our scores’ performance across different ancestries, finding improved cross-ancestry performance compared to previous approaches, especially in African and East Asian populations. This is likely due to the fact our scores are constructed using a method that incorporates functional genomic annotations on more than 7 million variants, enabling a degree of fine-mapping of causal variants shared across ancestries. We illustrate clinical utility through examining the risk reduction that could be achieved through embryo screening for type 2 diabetes: selecting among 10 embryos is expected to reduce absolute disease risk by 12-20% in families where both parents are affected, with similar relative risk reductions across ancestries. These findings establish a framework for implementing PGS in reproductive medicine while demonstrating both the technology’s potential for disease prevention and the methodological standards required for responsible clinical translation.
- Open Access
Psychiatric disorders converge on common pathways but diverge in cellular context, spatial distribution, and directionality of genetic effects
Psychiatric conditions share common genes, but mechanisms that differentiate diagnoses remain unclear. We present a multidimensional framework for functional analysis of rare copy number variants (CNVs) across 6 diagnostic categories, including schizophrenia (SCZ), autism (ASD), bipolar disorder (BD), depression (MDD), PTSD, and ADHD (N = 574,965). Using gene-set burden analysis (GSBA), we tested duplication (DUP) and deletion (DEL) burden across 2,645 functional gene sets defined by the intersections of pathways, cell types, and cortical regions. While diagnoses converge on shared pathways, mixed-effects modeling revealed divergence of pathway effects by cell type, brain region, and gene dosage. Factor analysis identified latent dimensions aligned with clinical axes. A primary factor (F1) captured reciprocal dose-dependent effects of DUP and DEL in SCZ reflecting positive and negative effects in excitatory versus inhibitory neurons and association versus sensory cortex. SCZ and ASD were both strongly aligned with F1 but with opposing directionalities. Orthogonal factors highlighted neuronal versus non-neuronal effects in mood disorders (F2) and differential spatial distributions of DEL effects in ADHD and MDD (F3). High-impact CNVs at 16p11.2 and 22q11.2 were enriched for combinations of cell-type-specific genes involved in pathways consistent with our broader findings. These results reveal molecular and cellular mechanisms that are broadly shared across psychiatric traits but differ between diagnostic categories in context and directionality.
Open AccessPsychiatric disorders converge on common pathways but diverge in cellular context, spatial distribution, and directionality of genetic effects
Psychiatric conditions share common genes, but mechanisms that differentiate diagnoses remain unclear. We present a multidimensional framework for functional analysis of rare copy number variants (CNVs) across 6 diagnostic categories, including schizophrenia (SCZ), autism (ASD), bipolar disorder (BD), depression (MDD), PTSD, and ADHD (N = 574,965). Using gene-set burden analysis (GSBA), we tested duplication (DUP) and deletion (DEL) burden across 2,645 functional gene sets defined by the intersections of pathways, cell types, and cortical regions. While diagnoses converge on shared pathways, mixed-effects modeling revealed divergence of pathway effects by cell type, brain region, and gene dosage. Factor analysis identified latent dimensions aligned with clinical axes. A primary factor (F1) captured reciprocal dose-dependent effects of DUP and DEL in SCZ reflecting positive and negative effects in excitatory versus inhibitory neurons and association versus sensory cortex. SCZ and ASD were both strongly aligned with F1 but with opposing directionalities. Orthogonal factors highlighted neuronal versus non-neuronal effects in mood disorders (F2) and differential spatial distributions of DEL effects in ADHD and MDD (F3). High-impact CNVs at 16p11.2 and 22q11.2 were enriched for combinations of cell-type-specific genes involved in pathways consistent with our broader findings. These results reveal molecular and cellular mechanisms that are broadly shared across psychiatric traits but differ between diagnostic categories in context and directionality.
- 16 May 2025
- Published by Elsevier in Electrochimica Acta
- Vol. 532
Effect of Mn substitution at the B-site of Ba0.2Sr0.8FeO3 as efficient electrode material for supercapacitor devices
- 16 May 2025
- Published by Elsevier in Electrochimica Acta
- Vol. 532
Effect of Mn substitution at the B-site of Ba0.2Sr0.8FeO3 as efficient electrode material for supercapacitor devices
- Open Access
Improving the discovery of rare variants associated with alcohol problems by leveraging machine learning phenotype prediction and functional information
Alcohol use disorder (AUD) is moderately heritable with significant social and economic impact. Genome-wide association studies (GWAS) have identified common variants associated with AUD, however, rare variant investigations have yet to achieve well-powered sample sizes. In this study, we conducted an interval-based exome-wide analysis of the Alcohol Use Disorder Identification Test Problems subscale (AUDIT-P) using both machine learning (ML) predicted risk and empirical functional weights. This research has been conducted using the UK Biobank Resource (application number 30782.) Filtering the 200k exome release to unrelated individuals of European ancestry resulted in a sample of 147,386 individuals with 51,357 observed and 96,029 unmeasured but predicted AUDIT-P for exome analysis. Sequence Kernel Association Test (SKAT/SKAT-O) was used for rare variant (Minor Allele Frequency (MAF) < 0.01) interval analyses using default and empirical weights. Empirical weights were constructed using annotations found significant by stratified LD Score Regression analysis of predicted AUDIT-P GWAS, providing prior functional weights specific to AUDIT-P. Using only samples with observed AUDIT-P yielded no significantly associated intervals. In contrast, ADH1C and THRA gene intervals were significant (False discovery rate (FDR) ADH1C gene (SKAT-O P Default = 1.06 x 10 -9 and P Empirical weight = 6.25 x 10 -11 ). These findings provide evidence for rare variant association of the ADH1C gene with the AUDIT-P and highlight the successful leveraging of ML to increase effective sample size and prior empirical functional weights based on common variant GWAS data to refine and increase the statistical significance in underpowered phenotypes.
Open AccessImproving the discovery of rare variants associated with alcohol problems by leveraging machine learning phenotype prediction and functional information
Alcohol use disorder (AUD) is moderately heritable with significant social and economic impact. Genome-wide association studies (GWAS) have identified common variants associated with AUD, however, rare variant investigations have yet to achieve well-powered sample sizes. In this study, we conducted an interval-based exome-wide analysis of the Alcohol Use Disorder Identification Test Problems subscale (AUDIT-P) using both machine learning (ML) predicted risk and empirical functional weights. This research has been conducted using the UK Biobank Resource (application number 30782.) Filtering the 200k exome release to unrelated individuals of European ancestry resulted in a sample of 147,386 individuals with 51,357 observed and 96,029 unmeasured but predicted AUDIT-P for exome analysis. Sequence Kernel Association Test (SKAT/SKAT-O) was used for rare variant (Minor Allele Frequency (MAF) < 0.01) interval analyses using default and empirical weights. Empirical weights were constructed using annotations found significant by stratified LD Score Regression analysis of predicted AUDIT-P GWAS, providing prior functional weights specific to AUDIT-P. Using only samples with observed AUDIT-P yielded no significantly associated intervals. In contrast, ADH1C and THRA gene intervals were significant (False discovery rate (FDR) ADH1C gene (SKAT-O P Default = 1.06 x 10 -9 and P Empirical weight = 6.25 x 10 -11 ). These findings provide evidence for rare variant association of the ADH1C gene with the AUDIT-P and highlight the successful leveraging of ML to increase effective sample size and prior empirical functional weights based on common variant GWAS data to refine and increase the statistical significance in underpowered phenotypes.
- 6 March 2023
- Published by Canakkale Onsekiz Mart University in Journal of Advanced Research in Natural and Applied Sciences
- Vol. 9 (1) , 237-250
Investigation of Current, Temperature, and Concentration Distribution of a Solid Oxide Fuel Cell with Mathematical Modelling Approach
The usage of environment-friendly energy converter devices is getting more and more attention as a result of environmental crises and regulations. SOFCs are among the highly efficient chemical to electrical energy converters. Thus, their effectiveness is a significant issue to improve. To increase the efficiency of SOFCs, their properties should be investigated. However, it is costly and time-consuming to test all the important characteristics of a solid oxide fuel cell by experimental methods. Computational methods can contribute to evaluate the influence of each parameter on the performance of the fuel cell. In this paper, a 3D mathematical model of a SOFC is presented. The model can describe the fuel cell’s temperature, the concentration of material, and current distribution inside the cell. Also, the influence of the flow pattern (co-current and counter-current) on the distribution plots and performance of the solid oxide fuel cell is investigated. The results demonstrate that the distribution of the current, concentration, and temperature is firmly related and wherever the concentration of reactants is higher, the temperature and current increase too. Also, the plots of power density and cell potential versus current were consistent with the results of the literature. Moreover, the comparison between two types of flow patterns shows that there is no significant variation when the type of current changes from counter to co-current. However, the performance of the SOFC is mildly better with a co-current flow pattern.
- 6 March 2023
- Published by Canakkale Onsekiz Mart University in Journal of Advanced Research in Natural and Applied Sciences
- Vol. 9 (1) , 237-250
Investigation of Current, Temperature, and Concentration Distribution of a Solid Oxide Fuel Cell with Mathematical Modelling Approach
The usage of environment-friendly energy converter devices is getting more and more attention as a result of environmental crises and regulations. SOFCs are among the highly efficient chemical to electrical energy converters. Thus, their effectiveness is a significant issue to improve. To increase the efficiency of SOFCs, their properties should be investigated. However, it is costly and time-consuming to test all the important characteristics of a solid oxide fuel cell by experimental methods. Computational methods can contribute to evaluate the influence of each parameter on the performance of the fuel cell. In this paper, a 3D mathematical model of a SOFC is presented. The model can describe the fuel cell’s temperature, the concentration of material, and current distribution inside the cell. Also, the influence of the flow pattern (co-current and counter-current) on the distribution plots and performance of the solid oxide fuel cell is investigated. The results demonstrate that the distribution of the current, concentration, and temperature is firmly related and wherever the concentration of reactants is higher, the temperature and current increase too. Also, the plots of power density and cell potential versus current were consistent with the results of the literature. Moreover, the comparison between two types of flow patterns shows that there is no significant variation when the type of current changes from counter to co-current. However, the performance of the SOFC is mildly better with a co-current flow pattern.